Recall Register

Food, drugs, devices › GE Healthcare, LLC

Device recall: GE Healthcare, Dash 3000, Dash 4000 and Dash 5000 Physiological Patient Monitor and accessories.

FDA enforcement event 63654 · Class II · initiated 13 Jun 2012 · status Terminated · terminated 25 Aug 2016

DeviceVoluntary: Firm initiated1 product recordWaukesha, WI

FDA enforcement event 63654 is a device recall by GE Healthcare, LLC of Waukesha, WI, initiated 13 Jun 2012 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 25 Aug 2016. Initiation: voluntary: firm initiated. GE Healthcare, LLC has 225 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

GE Healthcare, LLC, Waukesha, WI.

Reason for recall

"GE has become aware of multiple issues affecting the Dash 3000/4000/5000 Patient Monitor. These issues may occur when the Ethernet controller in the XPC823 CPU on the Dash and DashPort 2 motherboard functions intermittently. GE Healthcare has identified that these issues occur most often at sites with large Unity Network installations. It should be noted that the Dash 3000/4000/5000 patient m"

Distribution

"Nationwide Distribution - ALL STATES IN CONTINENTAL USA INCLUDING PR and DC excluding AK, DE, ND, and VT. ALGERIA, AUSTRALIA, ANGOLA, ARGENTINA, AUSTRIA, BAHAMAS, BAHRAIN, BANGLADESH, BELGIUM,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0813-2013GE Healthcare, Dash 3000, Dash 4000 and Dash 5000 Physiological Patient Monitor and accessories.119,262Class IITerminated20 Feb 2013

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
225events on this register for the firm

Other enforcement events for GE Healthcare, LLC

InitiatedProduct (first record)TypeClassRecords
27 Feb 2026SIGNA Premier systemsDeviceClass II1
15 Jul 2022(1) GE Centricity Universal Viewer 6.0, Model 2088026-9XX; (2) GE Centricity Universal Viewer 7.0, Model 5826659-0XX; (3DeviceClass II1
24 Jun 2022SIGNA Premier magnetic resonance scanner, model 5748519.DeviceClass II1
14 Jun 2022Centricity PACS Software Version 7.0 SP0.0.4.7DeviceClass II1
8 Jun 2022GE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images and data withinDeviceClass II1
2 Jun 2022Service manuals for the CT, PET, or NM table as follows: GT1700/GT1700V/VT1700, GT2000/VT2000, GT2000x/VT2000x, High CapDeviceClass II1
1 Jun 2022GE Healthcare Aisys CS2 Anesthesia System, Part number 1011-9050-000; and Avance CS2 and Avance CS2 Pro Anesthesia SysteDeviceClass I1
27 May 2022GE Healthcare Avance CS2, Avance CS2 Pro Anesthesia Systems, Part #1009-9050-000; and Aisys CS2 Anesthesia Systems, PartDeviceClass II1
10 May 2022CARESCAPE Central Station (CSCS) V2, Model numbers 2082278-001 and 2082279-001. Update 3/10/2023: The following FRU and DeviceClass II1
28 Apr 2022Centricity Universal Viewer Zero Footprint ClientDeviceClass II5

All 225 events for GE Healthcare, LLC

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "GE has become aware of multiple issues affecting the Dash 3000/4000/5000 Patient Monitor. These issues may occur when the Ethernet controller in the XPC823 CPU on the Dash and DashPort 2 motherboard functions intermittently. GE Healthcare has identified that these issues occur most often at sites with large Unity Network installations. It should be noted that the Dash 3000/4000/5000 patient m"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide Distribution - ALL STATES IN CONTINENTAL USA INCLUDING PR and DC excluding AK, DE, ND, and VT. ALGERIA, AUSTRALIA, ANGOLA, ARGENTINA, AUSTRIA, BAHAMAS, BAHRAIN, BANGLADESH, BELGIUM,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 25 Aug 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.